CRISPR/Cas systems usher in a new era of disease treatment and diagnosis
Abstract The discovery and development of the CRISPR/Cas system is a milestone in precise medicine. CRISPR/Cas nucleases, base-editing (BE) and prime-editing (PE) are three genome editing technologies derived from CRISPR/Cas. In recent years, CRISPR-based genome editing technologies have created imm...
Main Authors: | Ruiting Li, Qin Wang, Kaiqin She, Fang Lu, Yang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2022-10-01
|
Series: | Molecular Biomedicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43556-022-00095-y |
Similar Items
-
Recent advances in therapeutic CRISPR-Cas9 genome editing: mechanisms and applications
by: Lifang Zhou, et al.
Published: (2023-04-01) -
Engineering CRISPR for emerging therapeutic applications
by: Xiaoqi Sun, et al.
Published: (2024-12-01) -
Application of CRISPR/Cas9-mediated gene editing for abiotic stress management in crop plants
by: Manoj Kumar, et al.
Published: (2023-04-01) -
CRISPR/Cas9 or prime editing? – It depends on…
by: Schenke Dirk
Published: (2020-12-01) -
Advances in application of CRISPR-Cas13a system
by: Yue Zhang, et al.
Published: (2024-02-01)